In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths
Opoku Solomon1, *, Nyanor Isaac2
1 Department of Quality Control, Entrance Pharmaceuticals and Research Centre, No. 16 Okpoi Gonno, Spintex Road, Post Office Box CT 10805, Accra, Ghana
2 Sickle Pan Africa Research Consortium, Kumasi Centre for Sickle Cell Disease, Komfo Anokye Teaching Hospital, Kumasi, Ghana
Article Information
Article History:
Electronic publication date: 13/03/2019
Collection year: 2019
Article Metrics:
CrossRef Citations:
0
Total Statistics:
Full-Text HTML Views: 671
Abstract HTML Views: 700
PDF Downloads: 189
ePub Downloads: 226
Total Views/Downloads: 1786
Unique Statistics:
Full-Text HTML Views: 433
Abstract HTML Views: 332
PDF Downloads: 137
ePub Downloads: 153
Total Views/Downloads: 1055
Geographical View
© 2019 Solomon and Isaac.
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (
https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Peer Review Details |
Manuscript submitted on
|
Original Manuscript |
In Vitro Inhibition of Staphylococcus aureus subsp. aureus (ATCC® 6538™) by Artemether-Lumefantrine Tablets: A Comparative Study of Three Dosage Strengths |